Total raised
$5.0M
Last: Seed 2023-08
Stage
Seed
Founded
2020
Headcount
14
HQ
Haifa
Sector
Health Tech & Life Sciences
About
Nevia Bio is an innovative health technology company committed to transforming women's health through the discovery of biomarkers in vaginal fluid. Our mission is to develop non-invasive, AI-driven diagnostic solutions for early detection of gynecological cancers, with an initial focus on ovarian cancer.
By leveraging the world’s largest database of vaginal fluid and multi-omics data, Nevia Bio is pioneering a breakthrough diagnostic platform that has the potential to detect cancers at their earliest and most treatable stages, ultimately improving patient outcomes and reducing treatment costs.
Funding history · 3 rounds · $5.0M total
2023-08
Seed
$3.1M
2022-03
Convertible Debt
Undisclosed
2020-03
Pre-Seed
$1.9M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningDigital HealthcareMedical Decision SupportMedical DevicesMedical MonitorsDiagnostics Devices
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomen
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
artificial-intelligenceearly-detectionpersonalizationdigital-healthcarewomenwomen-healthcancernon-invasivebiomarkersdiagnosticscancer-diagnosticsremote-monitoringfemtech